WHO ICTRP trial
A multicenter clinical study for compound Huangdai tablet combined with…
ITMCTR1900002791 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR1900002791 |
|---|---|
| Public title | A multicenter clinical study for compound Huangdai tablet combined with Decitabine / CAG (HAG) regimen in the treatment of high risk MDS |
| Scientific title | Multicenter clinical study for integrated traditional Chinese and Western medicine in the treatment of high risk MDS |
| Primary sponsor | The First affiliated Hospital of Zhejiang Chinese Medical University |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | MDS |
| Interventions | Control group:Decitabine / CAG (HAG);Experimental group:compound Huangdai tablet combined with Decitabine / CAG (HAG) |
| Registration date | Nov 30, 2019 |
| Target size | Control group:40;Experimental group:40 |
| Secondary IDs | ChiCTR1900027826;ChiMCTR1900002791 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: